Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2004-02-23
2009-12-29
Whiteman, Brian (Department: 1635)
Chemistry: molecular biology and microbiology
Vector, per se
Reexamination Certificate
active
07638322
ABSTRACT:
Plasmids useful for treating ischemic disease, such as ischemic heart disease, are described. The plasmids express vascular endothelial growth factor (VEGF) under the control of a promoter (RTP801) that is up-regulated under hypoxic conditions. Pharmaceutical compositions for treating ischemic disease include mixtures of the hypoxia-regulated VEGF plasmids and pharmaceutically acceptable carriers. Methods for treating ischemic disease include administering such pharmaceutical compositions to a person in need of such treatment.
REFERENCES:
patent: 6548633 (2003-04-01), Edwards et al.
patent: 2003/0104973 (2003-06-01), Einat et al.
Su Hua et al: “Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model”; Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, DC, US, vol. 99, No. 14, Jul. 9, 2002, pp. 9480-9485.
Jeffrey M. Isner, Myocardial Gene Therapy, 415 Nature 234-239 (2002).
Minhyung Lee, et. al., SP-1 Dependent Regulation of the RTP801 Promotor and Its Application to Hypoxia-Inducible VEGF Plasmid for Ischemic Disease, 21 Pharaceutical Research, 736-741 (2004).
Tzipora Shoshani, et. al., Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in Apoptosis, 22 Molecular and Cellular Biology 2282-2293 (2002).
Seppo Yiä-Herttuala, et. al., Cardiovascular Gene Therapy, 355 The Lancet 213-222 (2000).
Kim Sung Wan
Lee Min-hyung
Clayton Howarth & Cannon, P.C.
University of Utah Research Foundation
Whiteman Brian
LandOfFree
Hypoxia inducible VEGF plasmid for ischemic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoxia inducible VEGF plasmid for ischemic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoxia inducible VEGF plasmid for ischemic disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4134708